Authors: Rabben, T Oye, I

Citation: T. Rabben et I. Oye, Interindividual differences in the analgesic response to ketamine in chronic orofacial pain, EUR J P-LON, 5(3), 2001, pp. 233-240

Authors: Willoch, F Rosen, G Tolle, TR Oye, I Wester, HJ Berner, N Schwaiger, M Bartenstein, P

Citation: F. Willoch et al., Phantom limb pain in the human brain: Unraveling neural circuitries of phantom limb sensations using positron emission tomography, ANN NEUROL, 48(6), 2000, pp. 842-849

Authors: Wester, HJ Willoch, F Tolle, TR Munz, F Herz, M Oye, I Schadrack, J Schwaiger, M Bartenstein, P

Citation: Hj. Wester et al., 6-O-(2-[F-18]Fluoroethyl)-6-O-desmethyldiprenorphine ([F-18]DPN): Synthesis, biologic evaluation, and comparison with [C-11]DPN in humans, J NUCL MED, 41(7), 2000, pp. 1279-1286

Authors: Vollenweider, FX Vontobel, P Oye, I Hell, D Leenders, KL

Citation: Fx. Vollenweider et al., Effects of (S)-ketamine on striatal dopamine: a [C-11]raclopride PET studyof a model psychosis in humans, J PSYCH RES, 34(1), 2000, pp. 35-43

Authors: Rabben, T Skjelbred, P Oye, I

Citation: T. Rabben et al., Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain, J PHARM EXP, 289(2), 1999, pp. 1060-1066

Authors: Kumlien, E Hartvig, P Valind, S Oye, I Tedroff, J Langstrom, B

Citation: E. Kumlien et al., NMDA-receptor activity visualized with (S)-[N-methyl-C-11]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy, EPILEPSIA, 40(1), 1999, pp. 30-37